The rise of Sildenafil initially drove a surge for major pharmaceutical companies, nevertheless recent shifts present a uncertain scenario for shareholders. Generic competitors are eroding earnings, and continued https://leaqfqx185973.ltfblog.com/39648830/viagra-and-big-pharma-a-precarious-investment